世界のコンパニオン診断市場：市場規模・現状・予測

• 英文タイトル：Global Companion Diagnostics Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7007 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、コンパニオン診断のグローバル市場について調査・分析したレポートで、種類別（ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、in situハイブリダイゼーション（ISH）、次世代シーケンシング（NGS））、用途別（病院、製薬会社、実験室、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・コンパニオン診断の世界市場規模 ・主要企業別市場シェア ・コンパニオン診断の世界市場規模：種類別（ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、in situハイブリダイゼーション（ISH）、次世代シーケンシング（NGS）） ・コンパニオン診断の世界市場規模：用途別（病院、製薬会社、実験室、その他） ・コンパニオン診断のアメリカ市場規模（種類別、用途別） ・コンパニオン診断のヨーロッパ市場規模（種類別、用途別） ・コンパニオン診断の中国市場規模（種類別、用途別） ・コンパニオン診断の日本市場規模（種類別、用途別） ・コンパニオン診断の東南アジア市場規模（種類別、用途別） ・コンパニオン診断のインド市場規模（種類別、用途別） ・コンパニオン診断の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・コンパニオン診断の世界市場予測（2019年-2025年） ・コンパニオン診断の地域別市場予測（2019年-2025年） ...

In 2018, the global Companion Diagnostics market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Companion Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Companion Diagnostics development in United States, Europe and China.

The key players covered in this study
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics

Market segment by Type, the product can be split into
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)

Market segment by Application, split into
Hospitals
Pharmaceutical Companies
Laboratories
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Companion Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Companion Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Companion Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Companion Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Polymerase Chain Reaction (PCR)
1.4.3 Immunohistochemistry (IHC)
1.4.4 In Situ Hybridization (ISH)
1.4.5 Next Generation Sequencing (NGS)
1.5 Market by Application
1.5.1 Global Companion Diagnostics Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Pharmaceutical Companies
1.5.4 Laboratories
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Companion Diagnostics Market Size
2.2 Companion Diagnostics Growth Trends by Regions
2.2.1 Companion Diagnostics Market Size by Regions (2014-2025)
2.2.2 Companion Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Companion Diagnostics Market Size by Manufacturers
3.1.1 Global Companion Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Companion Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Companion Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Companion Diagnostics Key Players Head office and Area Served
3.3 Key Players Companion Diagnostics Product/Solution/Service
3.4 Date of Enter into Companion Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Companion Diagnostics Market Size by Type (2014-2019)
4.2 Global Companion Diagnostics Market Size by Application (2014-2019)

5 United States
5.1 United States Companion Diagnostics Market Size (2014-2019)
5.2 Companion Diagnostics Key Players in United States
5.3 United States Companion Diagnostics Market Size by Type
5.4 United States Companion Diagnostics Market Size by Application

6 Europe
6.1 Europe Companion Diagnostics Market Size (2014-2019)
6.2 Companion Diagnostics Key Players in Europe
6.3 Europe Companion Diagnostics Market Size by Type
6.4 Europe Companion Diagnostics Market Size by Application

7 China
7.1 China Companion Diagnostics Market Size (2014-2019)
7.2 Companion Diagnostics Key Players in China
7.3 China Companion Diagnostics Market Size by Type
7.4 China Companion Diagnostics Market Size by Application

8 Japan
8.1 Japan Companion Diagnostics Market Size (2014-2019)
8.2 Companion Diagnostics Key Players in Japan
8.3 Japan Companion Diagnostics Market Size by Type
8.4 Japan Companion Diagnostics Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Companion Diagnostics Market Size (2014-2019)
9.2 Companion Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Companion Diagnostics Market Size by Type
9.4 Southeast Asia Companion Diagnostics Market Size by Application

10 India
10.1 India Companion Diagnostics Market Size (2014-2019)
10.2 Companion Diagnostics Key Players in India
10.3 India Companion Diagnostics Market Size by Type
10.4 India Companion Diagnostics Market Size by Application

11 Central & South America
11.1 Central & South America Companion Diagnostics Market Size (2014-2019)
11.2 Companion Diagnostics Key Players in Central & South America
11.3 Central & South America Companion Diagnostics Market Size by Type
11.4 Central & South America Companion Diagnostics Market Size by Application

12 International Players Profiles
12.1 Roche Holdings
12.1.1 Roche Holdings Company Details
12.1.2 Company Description and Business Overview
12.1.3 Companion Diagnostics Introduction
12.1.4 Roche Holdings Revenue in Companion Diagnostics Business (2014-2019)
12.1.5 Roche Holdings Recent Development
12.2 Abbott Laboratories
12.2.1 Abbott Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Companion Diagnostics Introduction
12.2.4 Abbott Laboratories Revenue in Companion Diagnostics Business (2014-2019)
12.2.5 Abbott Laboratories Recent Development
12.3 Thermo Fisher Scientific
12.3.1 Thermo Fisher Scientific Company Details
12.3.2 Company Description and Business Overview
12.3.3 Companion Diagnostics Introduction
12.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2014-2019)
12.3.5 Thermo Fisher Scientific Recent Development
12.4 Agilent Technologies
12.4.1 Agilent Technologies Company Details
12.4.2 Company Description and Business Overview
12.4.3 Companion Diagnostics Introduction
12.4.4 Agilent Technologies Revenue in Companion Diagnostics Business (2014-2019)
12.4.5 Agilent Technologies Recent Development
12.5 Life Technologies
12.5.1 Life Technologies Company Details
12.5.2 Company Description and Business Overview
12.5.3 Companion Diagnostics Introduction
12.5.4 Life Technologies Revenue in Companion Diagnostics Business (2014-2019)
12.5.5 Life Technologies Recent Development
12.6 GE Healthcare
12.6.1 GE Healthcare Company Details
12.6.2 Company Description and Business Overview
12.6.3 Companion Diagnostics Introduction
12.6.4 GE Healthcare Revenue in Companion Diagnostics Business (2014-2019)
12.6.5 GE Healthcare Recent Development
12.7 Agendia
12.7.1 Agendia Company Details
12.7.2 Company Description and Business Overview
12.7.3 Companion Diagnostics Introduction
12.7.4 Agendia Revenue in Companion Diagnostics Business (2014-2019)
12.7.5 Agendia Recent Development
12.8 Qiagen
12.8.1 Qiagen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Companion Diagnostics Introduction
12.8.4 Qiagen Revenue in Companion Diagnostics Business (2014-2019)
12.8.5 Qiagen Recent Development
12.9 Genomic Health
12.9.1 Genomic Health Company Details
12.9.2 Company Description and Business Overview
12.9.3 Companion Diagnostics Introduction
12.9.4 Genomic Health Revenue in Companion Diagnostics Business (2014-2019)
12.9.5 Genomic Health Recent Development
12.10 Myriad Genetics
12.10.1 Myriad Genetics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Companion Diagnostics Introduction
12.10.4 Myriad Genetics Revenue in Companion Diagnostics Business (2014-2019)
12.10.5 Myriad Genetics Recent Development
12.11 Advanced Cell Diagnostics
12.12 Danaher
12.13 Applied Proteomics

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Companion Diagnostics Key Market Segments
Table Key Players Companion Diagnostics Covered
Table Global Companion Diagnostics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Companion Diagnostics Market Size Market Share by Type 2014-2025
Figure Polymerase Chain Reaction (PCR) Figures
Table Key Players of Polymerase Chain Reaction (PCR)
Figure Immunohistochemistry (IHC) Figures
Table Key Players of Immunohistochemistry (IHC)
Figure In Situ Hybridization (ISH) Figures
Table Key Players of In Situ Hybridization (ISH)
Figure Next Generation Sequencing (NGS) Figures
Table Key Players of Next Generation Sequencing (NGS)
Table Global Companion Diagnostics Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Pharmaceutical Companies Case Studies
Figure Laboratories Case Studies
Figure Other Case Studies
Figure Companion Diagnostics Report Years Considered
Table Global Companion Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Companion Diagnostics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Companion Diagnostics Market Size by Regions 2014-2025 (Million US$)
Table Global Companion Diagnostics Market Size by Regions 2014-2019 (Million US$)
Table Global Companion Diagnostics Market Share by Regions 2014-2019
Figure Global Companion Diagnostics Market Share by Regions 2014-2019
Figure Global Companion Diagnostics Market Share by Regions 2019
Table Market Top Trends
Table Global Companion Diagnostics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Companion Diagnostics Market Share by Manufacturers (2014-2019)
Figure Global Companion Diagnostics Market Share by Manufacturers in 2018
Table Global Companion Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Companion Diagnostics Product/Solution/Service
Table Date of Enter into Companion Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Companion Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Global Companion Diagnostics Market Size Share by Type (2014-2019)
Figure Global Companion Diagnostics Market Size Market Share by Type (2014-2019)
Table Global Companion Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Global Companion Diagnostics Market Size Share by Application (2014-2019)
Figure Global Companion Diagnostics Market Size Market Share by Application (2014-2019)
Figure Global Companion Diagnostics Revenue Market Share by Application in 2018
Figure United States Companion Diagnostics Market Size 2014-2019 (Million US$)
Table United States Key Players Companion Diagnostics Revenue (2018-2019) (Million US$)
Table United States Key Players Companion Diagnostics Market Share (2018-2019)
Table United States Companion Diagnostics Market Size by Type (2014-2019) (Million US$)
Table United States Companion Diagnostics Market Share by Type (2014-2019)
Table United States Companion Diagnostics Market Size by Application (2014-2019) (Million US$)
Table United States Companion Diagnostics Market Share by Application (2014-2019)
Figure Europe Companion Diagnostics Market Size 2014-2019 (Million US$)
Table Europe Key Players Companion Diagnostics Revenue (2018-2019) (Million US$)
Table Europe Key Players Companion Diagnostics Market Share (2018-2019)
Table Europe Companion Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Europe Companion Diagnostics Market Share by Type (2014-2019)
Table Europe Companion Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Europe Companion Diagnostics Market Share by Application (2014-2019)
Figure China Companion Diagnostics Market Size 2014-2019 (Million US$)
Table China Key Players Companion Diagnostics Revenue (2018-2019) (Million US$)
Table China Key Players Companion Diagnostics Market Share (2018-2019)
Table China Companion Diagnostics Market Size by Type (2014-20189) (Million US$)
Table China Companion Diagnostics Market Share by Type (2014-2019)
Table China Companion Diagnostics Market Size by Application (2014-2019) (Million US$)
Table China Companion Diagnostics Market Share by Application (2014-2019)
Figure Japan Companion Diagnostics Market Size 2014-2019 (Million US$)
Table Japan Key Players Companion Diagnostics Revenue (2018-2019) (Million US$)
Table Japan Key Players Companion Diagnostics Market Share (2018-2019)
Table Japan Companion Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Japan Companion Diagnostics Market Share by Type (2014-2019)
Table Japan Companion Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Japan Companion Diagnostics Market Share by Application (2014-2019)
Figure Southeast Asia Companion Diagnostics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Companion Diagnostics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Companion Diagnostics Market Share (2018-2019)
Table Southeast Asia Companion Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Companion Diagnostics Market Share by Type (2014-2019)
Table Southeast Asia Companion Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Companion Diagnostics Market Share by Application (2014-2019)
Figure India Companion Diagnostics Market Size 2014-2019 (Million US$)
Table India Key Players Companion Diagnostics Revenue (2018-2019) (Million US$)
Table India Key Players Companion Diagnostics Market Share (2018-2019)
Table India Companion Diagnostics Market Size by Type (2014-2019) (Million US$)
Table India Companion Diagnostics Market Share by Type (2014-2019)
Table India Companion Diagnostics Market Size by Application (2014-2019) (Million US$)
Table India Companion Diagnostics Market Share by Application (2014-2019)
Figure Central & South America Companion Diagnostics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Companion Diagnostics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Companion Diagnostics Market Share (2018-2019)
Table Central & South America Companion Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Companion Diagnostics Market Share by Type (2014-2019)
Table Central & South America Companion Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Companion Diagnostics Market Share by Application (2014-2019)
Table Roche Holdings Company Details
Table Roche Holdings Revenue in Companion Diagnostics Business (2014-2019) (Million US$)
Figure Roche Holdings Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table Roche Holdings Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Companion Diagnostics Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Companion Diagnostics Business (2014-2019)(Million US$)
Figure Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table Thermo Fisher Scientific Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Companion Diagnostics Business (2014-2019)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table Agilent Technologies Recent Development
Table Life Technologies Company Details
Table Life Technologies Revenue in Companion Diagnostics Business (2014-2019)(Million US$)
Figure Life Technologies Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table Life Technologies Recent Development
Table GE Healthcare Company Details
Table GE Healthcare Revenue in Companion Diagnostics Business (2014-2019)(Million US$)
Figure GE Healthcare Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table GE Healthcare Recent Development
Table Agendia Company Details
Table Agendia Revenue in Companion Diagnostics Business (2014-2019)(Million US$)
Figure Agendia Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table Agendia Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Companion Diagnostics Business (2014-2019)(Million US$)
Figure Qiagen Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table Qiagen Recent Development
Table Genomic Health Company Details
Table Genomic Health Revenue in Companion Diagnostics Business (2014-2019)(Million US$)
Figure Genomic Health Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table Genomic Health Recent Development
Table Myriad Genetics Company Details
Table Myriad Genetics Revenue in Companion Diagnostics Business (2014-2019)(Million US$)
Figure Myriad Genetics Revenue Growth Rate in Companion Diagnostics Business (2014-2019)
Table Myriad Genetics Recent Development
Table Advanced Cell Diagnostics Company Details
Table Danaher Company Details
Table Applied Proteomics Company Details
Table Global Companion Diagnostics Market Size by Regions (Million US$) 2019-2025
Figure Global Companion Diagnostics Market Size Share by Regions (2019-2025)
Figure Global Companion Diagnostics Market Size Share by Regions in 2025
Figure United States Companion Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Companion Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure China Companion Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Companion Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Companion Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure India Companion Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Companion Diagnostics Market Size Forecast (2019-2025)(Million USD)
Table Global Companion Diagnostics Market Size by Product (2019-2025) (Million US$)
Figure Global Companion Diagnostics Market Size by Product (2019-2025)
Figure Global Companion Diagnostics Market Size by Product in 2025
Table Global Companion Diagnostics Market Size by Application (2019-2025) (Million US$)
Figure Global Companion Diagnostics Market Size by Application (2019-2025)
Figure Global Companion Diagnostics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---